|
Monday, March 3, 2008 — 8:00 AM - 1:00 PM
Convention Center 102/104/106
Click the button above to add this event to your Itinerary Planner...
COURSE DIRECTORS:
Julia A. Bridge, M.D., FACMG
University of Nebraska Medical Center
Omaha, NE
|
Accumulating discoveries of the biological mechanisms that control cell growth and differentiation, and developments in the clinical management of cancer, continue to expand the role of molecular technology in diagnostic surgical pathology. In this course, the basic principles of molecular pathology in cancer and their application to laboratory medicine will be emphasized in a format designed to be practical and straightforward. Specifically, this course is aimed at providing pathologists with a foundation in the practice of oncologic molecular pathology to include: nomenclature, commonly used techniques and their specimen requirements, assay selection and indications, diagnostic and prognostic utility, test turn-around-times, and quality assurance issues. Select cases may be presented to illustrate use in routine practice and serve as useful paradigms. Moreover, specific areas will be highlighted in which major advances can be expected and to which the basic principles learned can be applied.
Course Objectives:
- to present an overview of the basic genetic principles of common oncologic molecular diagnostic testing
- to provide participants with a working knowledge of tests available in oncologic molecular pathology as well as their application and interpretation in screening, diagnosis, monitoring, and treatment of cancer
AGENDA
| 8:00 | Introduction
Julia A. Bridge, M.D., FACMG |
| 8:10 | Cytogenetic and Molecular Genetic Pathology of Bone and
Soft Tissue Tumors
Julia A. Bridge, M.D |
| 8:40 | Integration of the Molecular Classification of Breast Cancer into
the Routine Diagnostic Workup of Cases
Allen M. Gown, MD, PheonPath Laboratories, Seattle, WA |
| 9:10 | Molecular Predictive Markers for Targeted Therapies of
Lung Cancer
Marc Ladanyi, M.D., Memorial Sloan-Kettering Cancer Center, New York, NY |
| 9:40 | Molecular Diagnostics of Gliomas
Arie Perry, M.D., Washington University School of Medicine, St. Louis, MO |
| 10:10 | Break (Coffee available in Exhibit Hall A) |
| 10:40 | The Basis and Rational Use of Molecular Testing in
Lymphoma
Adam Bagg, M.D., University of Pennsylvania, Philadelphia, PA |
| 11:10 | Molecular Pathology of Endocrine Neoplasms
Jennifer L. Hunt, M.D., M.Ed,; Cleveland Clinic Foundation,
Cleveland, OH |
| 11:40 | Colorectal Carcinoma: Molecular Pathology and Clinical
Practice
Stanley R. Hamilton, M.D., The University of Texas M.D. Anderson Cancer Center, Houston, TX |
| 12:10 | Emerging Understanding of Gene Fusion Prostate Cancer
Mark A. Rubin, M.D., Weill Cornell Medical College,
New York, NY |
| 12:40 | Question Period and Concluding Remarks |
|
|
